Antoine Deschildre, MD, PhD

Pediatric Chest Physician
CHU Lille, France

Abstracts(s):

• PC3007: Dupilumab Efficacy in Children with Moderate-to-severe Type 2 Asthma Analyzed by High- or Medium-dose of Inhaled Corticosteroids at Baseline: LIBERTY ASTHMA VOYAGE Study
  Monday, October 10, 2022

  1:30 PM – 2:30 PM US PDT

• PC3012: Impact of Patient Demographic and Disease Characteristics on the Efficacy of Dupilumab in Children with Asthma in the VOYAGE Study
  Monday, October 10, 2022

  1:30 PM – 2:30 PM US PDT